GO:0005515 | protein binding | 72.41% (84/116) | 0.94 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 38.79% (45/116) | 1.65 | 0.0 | 0.0 |
GO:0005829 | cytosol | 41.38% (48/116) | 1.54 | 0.0 | 0.0 |
GO:0005488 | binding | 81.03% (94/116) | 0.69 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 50.86% (59/116) | 1.19 | 0.0 | 0.0 |
GO:0060255 | regulation of macromolecule metabolic process | 41.38% (48/116) | 1.39 | 0.0 | 0.0 |
GO:0019222 | regulation of metabolic process | 45.69% (53/116) | 1.25 | 0.0 | 0.0 |
GO:0050794 | regulation of cellular process | 57.76% (67/116) | 0.98 | 0.0 | 0.0 |
GO:0048518 | positive regulation of biological process | 41.38% (48/116) | 1.26 | 0.0 | 0.0 |
GO:0050789 | regulation of biological process | 61.21% (71/116) | 0.87 | 0.0 | 0.0 |
GO:0071840 | cellular component organization or biogenesis | 41.38% (48/116) | 1.25 | 0.0 | 0.0 |
GO:0065007 | biological regulation | 64.66% (75/116) | 0.82 | 0.0 | 0.0 |
GO:0051171 | regulation of nitrogen compound metabolic process | 37.07% (43/116) | 1.35 | 0.0 | 0.0 |
GO:0019538 | protein metabolic process | 35.34% (41/116) | 1.39 | 0.0 | 0.0 |
GO:0010468 | regulation of gene expression | 34.48% (40/116) | 1.43 | 0.0 | 0.0 |
GO:0048523 | negative regulation of cellular process | 31.9% (37/116) | 1.51 | 0.0 | 0.0 |
GO:0016043 | cellular component organization | 39.66% (46/116) | 1.28 | 0.0 | 0.0 |
GO:0051247 | positive regulation of protein metabolic process | 15.52% (18/116) | 2.52 | 0.0 | 0.0 |
GO:0005654 | nucleoplasm | 19.83% (23/116) | 2.12 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 22.41% (26/116) | 1.91 | 0.0 | 1e-06 |
GO:0080090 | regulation of primary metabolic process | 37.93% (44/116) | 1.29 | 0.0 | 1e-06 |
GO:0006396 | RNA processing | 18.97% (22/116) | 2.13 | 0.0 | 1e-06 |
GO:0006807 | nitrogen compound metabolic process | 53.45% (62/116) | 0.94 | 0.0 | 1e-06 |
GO:0003674 | molecular_function | 84.48% (98/116) | 0.5 | 0.0 | 1e-06 |
GO:0048519 | negative regulation of biological process | 37.07% (43/116) | 1.27 | 0.0 | 1e-06 |
GO:0043412 | macromolecule modification | 31.9% (37/116) | 1.41 | 0.0 | 1e-06 |
GO:0008150 | biological_process | 85.34% (99/116) | 0.47 | 0.0 | 2e-06 |
GO:0051246 | regulation of protein metabolic process | 20.69% (24/116) | 1.9 | 0.0 | 2e-06 |
GO:0036211 | protein modification process | 28.45% (33/116) | 1.48 | 0.0 | 3e-06 |
GO:0005575 | cellular_component | 84.48% (98/116) | 0.47 | 0.0 | 3e-06 |
GO:0009987 | cellular process | 76.72% (89/116) | 0.56 | 0.0 | 4e-06 |
GO:0031323 | regulation of cellular metabolic process | 37.07% (43/116) | 1.18 | 0.0 | 5e-06 |
GO:0022607 | cellular component assembly | 21.55% (25/116) | 1.77 | 0.0 | 5e-06 |
GO:0110165 | cellular anatomical entity | 82.76% (96/116) | 0.46 | 0.0 | 1.2e-05 |
GO:0048522 | positive regulation of cellular process | 32.76% (38/116) | 1.24 | 0.0 | 1.4e-05 |
GO:0044238 | primary metabolic process | 55.17% (64/116) | 0.79 | 0.0 | 1.5e-05 |
GO:0010604 | positive regulation of macromolecule metabolic process | 24.14% (28/116) | 1.53 | 0.0 | 2e-05 |
GO:0051641 | cellular localization | 19.83% (23/116) | 1.75 | 0.0 | 2.2e-05 |
GO:0006139 | nucleobase-containing compound metabolic process | 26.72% (31/116) | 1.4 | 0.0 | 2.5e-05 |
GO:0003723 | RNA binding | 20.69% (24/116) | 1.67 | 0.0 | 2.8e-05 |
GO:0070646 | protein modification by small protein removal | 6.03% (7/116) | 3.97 | 0.0 | 2.8e-05 |
GO:0046907 | intracellular transport | 14.66% (17/116) | 2.08 | 1e-06 | 4e-05 |
GO:0090304 | nucleic acid metabolic process | 23.28% (27/116) | 1.5 | 1e-06 | 4.6e-05 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 22.41% (26/116) | 1.53 | 1e-06 | 5.2e-05 |
GO:0006996 | organelle organization | 22.41% (26/116) | 1.52 | 1e-06 | 5.3e-05 |
GO:0043933 | protein-containing complex organization | 15.52% (18/116) | 1.96 | 1e-06 | 5.7e-05 |
GO:0051649 | establishment of localization in cell | 15.52% (18/116) | 1.94 | 1e-06 | 6.7e-05 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 3.45% (4/116) | 5.7 | 1e-06 | 6.7e-05 |
GO:0019899 | enzyme binding | 18.1% (21/116) | 1.72 | 1e-06 | 7.9e-05 |
GO:0031401 | positive regulation of protein modification process | 9.48% (11/116) | 2.66 | 1e-06 | 9e-05 |
GO:1901564 | organonitrogen compound metabolic process | 41.38% (48/116) | 0.93 | 2e-06 | 9.6e-05 |
GO:1901363 | heterocyclic compound binding | 44.83% (52/116) | 0.86 | 2e-06 | 0.000112 |
GO:0034470 | ncRNA processing | 11.21% (13/116) | 2.32 | 2e-06 | 0.00013 |
GO:0097159 | organic cyclic compound binding | 44.83% (52/116) | 0.85 | 2e-06 | 0.000134 |
GO:0048583 | regulation of response to stimulus | 30.17% (35/116) | 1.16 | 3e-06 | 0.000144 |
GO:0000159 | protein phosphatase type 2A complex | 3.45% (4/116) | 5.35 | 3e-06 | 0.000154 |
GO:0033036 | macromolecule localization | 17.24% (20/116) | 1.7 | 3e-06 | 0.000157 |
GO:0046599 | regulation of centriole replication | 2.59% (3/116) | 6.66 | 3e-06 | 0.000159 |
GO:1902494 | catalytic complex | 16.38% (19/116) | 1.75 | 3e-06 | 0.00017 |
GO:0034660 | ncRNA metabolic process | 12.07% (14/116) | 2.15 | 3e-06 | 0.000177 |
GO:0006508 | proteolysis | 13.79% (16/116) | 1.96 | 4e-06 | 0.000178 |
GO:0009893 | positive regulation of metabolic process | 24.14% (28/116) | 1.32 | 4e-06 | 0.0002 |
GO:0031329 | regulation of cellular catabolic process | 10.34% (12/116) | 2.35 | 5e-06 | 0.000224 |
GO:0003676 | nucleic acid binding | 31.03% (36/116) | 1.09 | 5e-06 | 0.00023 |
GO:0044237 | cellular metabolic process | 54.31% (63/116) | 0.68 | 5e-06 | 0.000233 |
GO:0051179 | localization | 29.31% (34/116) | 1.13 | 5e-06 | 0.000248 |
GO:0008152 | metabolic process | 60.34% (70/116) | 0.6 | 6e-06 | 0.000261 |
GO:0031399 | regulation of protein modification process | 12.07% (14/116) | 2.08 | 6e-06 | 0.000261 |
GO:0006606 | protein import into nucleus | 4.31% (5/116) | 4.29 | 6e-06 | 0.000269 |
GO:0015031 | protein transport | 12.07% (14/116) | 2.05 | 7e-06 | 0.000326 |
GO:0072594 | establishment of protein localization to organelle | 7.76% (9/116) | 2.75 | 8e-06 | 0.000364 |
GO:0023051 | regulation of signaling | 20.69% (24/116) | 1.41 | 9e-06 | 0.000365 |
GO:0097194 | execution phase of apoptosis | 1.72% (2/116) | 8.4 | 9e-06 | 0.000367 |
GO:0070727 | cellular macromolecule localization | 15.52% (18/116) | 1.71 | 9e-06 | 0.000385 |
GO:0010646 | regulation of cell communication | 20.69% (24/116) | 1.4 | 1e-05 | 0.000396 |
GO:0071704 | organic substance metabolic process | 56.9% (66/116) | 0.62 | 1e-05 | 0.000418 |
GO:0046483 | heterocycle metabolic process | 28.45% (33/116) | 1.11 | 1.1e-05 | 0.000422 |
GO:0009894 | regulation of catabolic process | 11.21% (13/116) | 2.11 | 1.1e-05 | 0.000425 |
GO:0048869 | cellular developmental process | 19.83% (23/116) | 1.41 | 1.4e-05 | 0.000537 |
GO:0006607 | NLS-bearing protein import into nucleus | 2.59% (3/116) | 5.98 | 1.4e-05 | 0.000538 |
GO:0019220 | regulation of phosphate metabolic process | 9.48% (11/116) | 2.31 | 1.5e-05 | 0.000551 |
GO:0045184 | establishment of protein localization | 12.07% (14/116) | 1.96 | 1.5e-05 | 0.000563 |
GO:0051174 | regulation of phosphorus metabolic process | 9.48% (11/116) | 2.29 | 1.7e-05 | 0.000623 |
GO:0040012 | regulation of locomotion | 6.9% (8/116) | 2.82 | 2e-05 | 0.000716 |
GO:0016579 | protein deubiquitination | 4.31% (5/116) | 3.94 | 2e-05 | 0.000726 |
GO:0051170 | import into nucleus | 4.31% (5/116) | 3.91 | 2.2e-05 | 0.000783 |
GO:0034641 | cellular nitrogen compound metabolic process | 28.45% (33/116) | 1.06 | 2.2e-05 | 0.000784 |
GO:0043228 | non-membrane-bounded organelle | 21.55% (25/116) | 1.29 | 2.3e-05 | 0.0008 |
GO:0043232 | intracellular non-membrane-bounded organelle | 21.55% (25/116) | 1.29 | 2.3e-05 | 0.0008 |
GO:0046600 | negative regulation of centriole replication | 1.72% (2/116) | 7.81 | 2.6e-05 | 0.00089 |
GO:0009966 | regulation of signal transduction | 18.97% (22/116) | 1.39 | 2.7e-05 | 0.000902 |
GO:0034504 | protein localization to nucleus | 5.17% (6/116) | 3.33 | 3.2e-05 | 0.00106 |
GO:0034248 | regulation of cellular amide metabolic process | 8.62% (10/116) | 2.33 | 3.3e-05 | 0.001079 |
GO:0008104 | protein localization | 13.79% (16/116) | 1.69 | 3.5e-05 | 0.001135 |
GO:0140513 | nuclear protein-containing complex | 12.93% (15/116) | 1.77 | 3.5e-05 | 0.00114 |
GO:2000145 | regulation of cell motility | 6.03% (7/116) | 2.95 | 3.8e-05 | 0.001172 |
GO:0070122 | obsolete isopeptidase activity | 2.59% (3/116) | 5.52 | 3.8e-05 | 0.001177 |
GO:0010608 | post-transcriptional regulation of gene expression | 9.48% (11/116) | 2.16 | 3.7e-05 | 0.001178 |
GO:0019783 | ubiquitin-like protein peptidase activity | 4.31% (5/116) | 3.74 | 3.9e-05 | 0.001187 |
GO:0030182 | neuron differentiation | 4.31% (5/116) | 3.75 | 3.7e-05 | 0.00119 |
GO:0051234 | establishment of localization | 25.0% (29/116) | 1.11 | 4.5e-05 | 0.001379 |
GO:0010562 | positive regulation of phosphorus metabolic process | 6.03% (7/116) | 2.89 | 4.9e-05 | 0.001465 |
GO:0045937 | positive regulation of phosphate metabolic process | 6.03% (7/116) | 2.89 | 4.9e-05 | 0.001465 |
GO:0031324 | negative regulation of cellular metabolic process | 16.38% (19/116) | 1.46 | 5.5e-05 | 0.00157 |
GO:0065003 | protein-containing complex assembly | 12.07% (14/116) | 1.79 | 5.3e-05 | 0.001571 |
GO:0008287 | protein serine/threonine phosphatase complex | 3.45% (4/116) | 4.29 | 5.5e-05 | 0.001571 |
GO:1903293 | phosphatase complex | 3.45% (4/116) | 4.29 | 5.5e-05 | 0.001571 |
GO:0006810 | transport | 24.14% (28/116) | 1.12 | 5.4e-05 | 0.001587 |
GO:0071705 | nitrogen compound transport | 14.66% (17/116) | 1.57 | 5.8e-05 | 0.001643 |
GO:0045727 | positive regulation of translation | 5.17% (6/116) | 3.15 | 6.3e-05 | 0.001744 |
GO:0001732 | formation of cytoplasmic translation initiation complex | 2.59% (3/116) | 5.23 | 7.1e-05 | 0.001935 |
GO:0010556 | regulation of macromolecule biosynthetic process | 23.28% (27/116) | 1.13 | 7.2e-05 | 0.001943 |
GO:0031325 | positive regulation of cellular metabolic process | 19.83% (23/116) | 1.26 | 7.1e-05 | 0.001947 |
GO:0019888 | protein phosphatase regulator activity | 3.45% (4/116) | 4.19 | 7.2e-05 | 0.001958 |
GO:0019208 | phosphatase regulator activity | 3.45% (4/116) | 4.15 | 8e-05 | 0.002135 |
GO:0009967 | positive regulation of signal transduction | 10.34% (12/116) | 1.92 | 8.3e-05 | 0.002204 |
GO:0006913 | nucleocytoplasmic transport | 5.17% (6/116) | 3.07 | 8.7e-05 | 0.002279 |
GO:0051169 | nuclear transport | 5.17% (6/116) | 3.06 | 9.1e-05 | 0.002364 |
GO:0048471 | perinuclear region of cytoplasm | 6.9% (8/116) | 2.5 | 9.2e-05 | 0.002368 |
GO:0043226 | organelle | 57.76% (67/116) | 0.52 | 9.6e-05 | 0.002441 |
GO:0008180 | COP9 signalosome | 2.59% (3/116) | 5.07 | 9.8e-05 | 0.00247 |
GO:0033043 | regulation of organelle organization | 9.48% (11/116) | 2.0 | 0.000105 | 0.002636 |
GO:0009889 | regulation of biosynthetic process | 25.86% (30/116) | 1.02 | 0.000107 | 0.002658 |
GO:0010824 | regulation of centrosome duplication | 2.59% (3/116) | 5.03 | 0.000108 | 0.002663 |
GO:0065008 | regulation of biological quality | 24.14% (28/116) | 1.06 | 0.000109 | 0.002663 |
GO:0006417 | regulation of translation | 7.76% (9/116) | 2.27 | 0.00011 | 0.002687 |
GO:0140096 | catalytic activity, acting on a protein | 22.41% (26/116) | 1.12 | 0.000113 | 0.002731 |
GO:0061024 | membrane organization | 7.76% (9/116) | 2.26 | 0.000116 | 0.002774 |
GO:0050686 | negative regulation of mRNA processing | 2.59% (3/116) | 4.98 | 0.000119 | 0.002797 |
GO:0007005 | mitochondrion organization | 5.17% (6/116) | 2.99 | 0.000118 | 0.002814 |
GO:0033365 | protein localization to organelle | 8.62% (10/116) | 2.1 | 0.000121 | 0.00284 |
GO:0034250 | positive regulation of cellular amide metabolic process | 5.17% (6/116) | 2.97 | 0.000126 | 0.002909 |
GO:0034976 | response to endoplasmic reticulum stress | 5.17% (6/116) | 2.97 | 0.000126 | 0.002909 |
GO:0033290 | eukaryotic 48S preinitiation complex | 2.59% (3/116) | 4.94 | 0.00013 | 0.002934 |
GO:0001569 | branching involved in blood vessel morphogenesis | 1.72% (2/116) | 6.81 | 0.00013 | 0.00295 |
GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation | 1.72% (2/116) | 6.81 | 0.00013 | 0.00295 |
GO:0032502 | developmental process | 43.1% (50/116) | 0.67 | 0.000134 | 0.002997 |
GO:0046605 | regulation of centrosome cycle | 2.59% (3/116) | 4.89 | 0.000142 | 0.003165 |
GO:0035639 | purine ribonucleoside triphosphate binding | 15.52% (18/116) | 1.4 | 0.000149 | 0.003258 |
GO:0018208 | peptidyl-proline modification | 3.45% (4/116) | 3.92 | 0.000148 | 0.003263 |
GO:0043229 | intracellular organelle | 56.9% (66/116) | 0.51 | 0.000162 | 0.003528 |
GO:0016071 | mRNA metabolic process | 9.48% (11/116) | 1.92 | 0.000166 | 0.003574 |
GO:0023056 | positive regulation of signaling | 10.34% (12/116) | 1.81 | 0.000171 | 0.003674 |
GO:1901360 | organic cyclic compound metabolic process | 30.17% (35/116) | 0.87 | 0.000184 | 0.00389 |
GO:0006886 | intracellular protein transport | 8.62% (10/116) | 2.03 | 0.000183 | 0.003897 |
GO:0010647 | positive regulation of cell communication | 10.34% (12/116) | 1.79 | 0.000191 | 0.004019 |
GO:0008637 | apoptotic mitochondrial changes | 2.59% (3/116) | 4.73 | 0.000199 | 0.004124 |
GO:0016282 | eukaryotic 43S preinitiation complex | 2.59% (3/116) | 4.73 | 0.000199 | 0.004124 |
GO:0003743 | translation initiation factor activity | 3.45% (4/116) | 3.8 | 0.000206 | 0.004242 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 15.52% (18/116) | 1.36 | 0.000212 | 0.004332 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 22.41% (26/116) | 1.06 | 0.000219 | 0.004447 |
GO:0051640 | organelle localization | 6.9% (8/116) | 2.31 | 0.000223 | 0.00449 |
GO:1902531 | regulation of intracellular signal transduction | 9.48% (11/116) | 1.87 | 0.000228 | 0.004562 |
GO:0010826 | negative regulation of centrosome duplication | 1.72% (2/116) | 6.4 | 0.000242 | 0.004717 |
GO:0046606 | negative regulation of centrosome cycle | 1.72% (2/116) | 6.4 | 0.000242 | 0.004717 |
GO:0050896 | response to stimulus | 55.17% (64/116) | 0.51 | 0.000239 | 0.004759 |
GO:0101005 | deubiquitinase activity | 3.45% (4/116) | 3.74 | 0.000241 | 0.004762 |
GO:0051716 | cellular response to stimulus | 27.59% (32/116) | 0.91 | 0.000246 | 0.004771 |
GO:0031156 | regulation of sorocarp development | 2.59% (3/116) | 4.62 | 0.00025 | 0.00482 |
GO:0006796 | phosphate-containing compound metabolic process | 18.97% (22/116) | 1.17 | 0.000255 | 0.004893 |
GO:0010605 | negative regulation of macromolecule metabolic process | 17.24% (20/116) | 1.24 | 0.000258 | 0.004916 |
GO:1903312 | negative regulation of mRNA metabolic process | 3.45% (4/116) | 3.68 | 0.000279 | 0.005286 |
GO:0030334 | regulation of cell migration | 5.17% (6/116) | 2.75 | 0.000285 | 0.00535 |
GO:0035304 | regulation of protein dephosphorylation | 3.45% (4/116) | 3.64 | 0.000311 | 0.005709 |
GO:0075522 | IRES-dependent viral translational initiation | 1.72% (2/116) | 6.23 | 0.00031 | 0.005725 |
GO:0010515 | negative regulation of induction of conjugation with cellular fusion | 1.72% (2/116) | 6.23 | 0.00031 | 0.005725 |
GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m | 1.72% (2/116) | 6.23 | 0.00031 | 0.005725 |
GO:0006793 | phosphorus metabolic process | 18.97% (22/116) | 1.14 | 0.000324 | 0.005883 |
GO:0051050 | positive regulation of transport | 6.9% (8/116) | 2.23 | 0.000323 | 0.005893 |
GO:0065009 | regulation of molecular function | 13.79% (16/116) | 1.41 | 0.000329 | 0.005924 |
GO:0050792 | regulation of viral process | 3.45% (4/116) | 3.62 | 0.000334 | 0.005979 |
GO:0051253 | negative regulation of RNA metabolic process | 11.21% (13/116) | 1.61 | 0.000338 | 0.006018 |
GO:0005789 | endoplasmic reticulum membrane | 9.48% (11/116) | 1.8 | 0.000342 | 0.006064 |
GO:0030097 | hemopoiesis | 3.45% (4/116) | 3.6 | 0.000345 | 0.006082 |
GO:0042981 | regulation of apoptotic process | 7.76% (9/116) | 2.05 | 0.000354 | 0.006193 |
GO:0031326 | regulation of cellular biosynthetic process | 24.14% (28/116) | 0.96 | 0.000358 | 0.00623 |
GO:0071782 | endoplasmic reticulum tubular network | 3.45% (4/116) | 3.58 | 0.00037 | 0.006399 |
GO:0032555 | purine ribonucleotide binding | 15.52% (18/116) | 1.29 | 0.000374 | 0.006448 |
GO:0005856 | cytoskeleton | 6.9% (8/116) | 2.2 | 0.000383 | 0.006492 |
GO:0051252 | regulation of RNA metabolic process | 20.69% (24/116) | 1.06 | 0.000382 | 0.006506 |
GO:0031674 | I band | 1.72% (2/116) | 6.07 | 0.000387 | 0.006515 |
GO:0006725 | cellular aromatic compound metabolic process | 27.59% (32/116) | 0.87 | 0.000381 | 0.006523 |
GO:0000413 | protein peptidyl-prolyl isomerization | 2.59% (3/116) | 4.4 | 0.0004 | 0.00662 |
GO:0030154 | cell differentiation | 12.93% (15/116) | 1.45 | 0.000398 | 0.006626 |
GO:0010564 | regulation of cell cycle process | 7.76% (9/116) | 2.02 | 0.000398 | 0.006659 |
GO:0017076 | purine nucleotide binding | 15.52% (18/116) | 1.28 | 0.000404 | 0.006663 |
GO:0030139 | endocytic vesicle | 4.31% (5/116) | 3.0 | 0.000422 | 0.006882 |
GO:0070993 | translation preinitiation complex | 2.59% (3/116) | 4.37 | 0.000425 | 0.006888 |
GO:0035303 | regulation of dephosphorylation | 3.45% (4/116) | 3.53 | 0.000422 | 0.00691 |
GO:0010628 | positive regulation of gene expression | 8.62% (10/116) | 1.87 | 0.000429 | 0.006921 |
GO:0048284 | organelle fusion | 4.31% (5/116) | 3.0 | 0.000431 | 0.006922 |
GO:0048140 | male germ-line cyst encapsulation | 1.72% (2/116) | 5.94 | 0.000472 | 0.007417 |
GO:0043653 | mitochondrial fragmentation involved in apoptotic process | 1.72% (2/116) | 5.94 | 0.000472 | 0.007417 |
GO:0050790 | regulation of catalytic activity | 10.34% (12/116) | 1.64 | 0.000475 | 0.007426 |
GO:0048513 | animal organ development | 9.48% (11/116) | 1.74 | 0.000469 | 0.007453 |
GO:0098796 | membrane protein complex | 7.76% (9/116) | 1.99 | 0.000468 | 0.007464 |
GO:0042127 | regulation of cell population proliferation | 8.62% (10/116) | 1.85 | 0.000495 | 0.007694 |
GO:1990904 | ribonucleoprotein complex | 9.48% (11/116) | 1.73 | 0.000502 | 0.007731 |
GO:0043065 | positive regulation of apoptotic process | 4.31% (5/116) | 2.95 | 0.0005 | 0.007745 |
GO:0022618 | ribonucleoprotein complex assembly | 5.17% (6/116) | 2.59 | 0.00051 | 0.007816 |
GO:0007281 | germ cell development | 4.31% (5/116) | 2.94 | 0.000521 | 0.007873 |
GO:0003712 | transcription coregulator activity | 6.03% (7/116) | 2.33 | 0.000519 | 0.007875 |
GO:0032553 | ribonucleotide binding | 15.52% (18/116) | 1.25 | 0.000518 | 0.007906 |
GO:0071702 | organic substance transport | 14.66% (17/116) | 1.3 | 0.000529 | 0.007948 |
GO:0042802 | identical protein binding | 17.24% (20/116) | 1.16 | 0.000536 | 0.008012 |
GO:0007029 | endoplasmic reticulum organization | 2.59% (3/116) | 4.23 | 0.000566 | 0.008416 |
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 2.59% (3/116) | 4.2 | 0.000597 | 0.00884 |
GO:0006914 | autophagy | 4.31% (5/116) | 2.89 | 0.000613 | 0.008944 |
GO:0016032 | viral process | 4.31% (5/116) | 2.89 | 0.000613 | 0.008944 |
GO:0043087 | regulation of GTPase activity | 3.45% (4/116) | 3.39 | 0.000609 | 0.008978 |
GO:0003299 | muscle hypertrophy in response to stress | 1.72% (2/116) | 5.7 | 0.000667 | 0.009373 |
GO:0014887 | cardiac muscle adaptation | 1.72% (2/116) | 5.7 | 0.000667 | 0.009373 |
GO:0014898 | cardiac muscle hypertrophy in response to stress | 1.72% (2/116) | 5.7 | 0.000667 | 0.009373 |
GO:0034260 | negative regulation of GTPase activity | 1.72% (2/116) | 5.7 | 0.000667 | 0.009373 |
GO:0061919 | process utilizing autophagic mechanism | 4.31% (5/116) | 2.86 | 0.000663 | 0.009492 |
GO:1903530 | regulation of secretion by cell | 4.31% (5/116) | 2.86 | 0.000663 | 0.009492 |
GO:0007166 | cell surface receptor signaling pathway | 6.03% (7/116) | 2.26 | 0.00068 | 0.009512 |
GO:0051093 | negative regulation of developmental process | 9.48% (11/116) | 1.68 | 0.000657 | 0.009542 |
GO:0071826 | ribonucleoprotein complex subunit organization | 5.17% (6/116) | 2.51 | 0.00069 | 0.009574 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 13.79% (16/116) | 1.32 | 0.000662 | 0.009577 |
GO:0043168 | anion binding | 18.1% (21/116) | 1.1 | 0.000689 | 0.009598 |
GO:0001932 | regulation of protein phosphorylation | 6.03% (7/116) | 2.26 | 0.000704 | 0.009724 |
GO:0001934 | positive regulation of protein phosphorylation | 4.31% (5/116) | 2.82 | 0.000757 | 0.01041 |
GO:0048138 | germ-line cyst encapsulation | 1.72% (2/116) | 5.59 | 0.000776 | 0.010574 |
GO:0007520 | myoblast fusion | 1.72% (2/116) | 5.59 | 0.000776 | 0.010574 |
GO:0048856 | anatomical structure development | 32.76% (38/116) | 0.72 | 0.000788 | 0.010637 |
GO:0050821 | protein stabilization | 4.31% (5/116) | 2.81 | 0.000786 | 0.010663 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 11.21% (13/116) | 1.48 | 0.000802 | 0.010782 |
GO:0007088 | regulation of mitotic nuclear division | 3.45% (4/116) | 3.26 | 0.00085 | 0.011371 |
GO:0005524 | ATP binding | 12.93% (15/116) | 1.34 | 0.000858 | 0.011386 |
GO:0048193 | Golgi vesicle transport | 5.17% (6/116) | 2.45 | 0.000855 | 0.011398 |
GO:0036099 | female germ-line stem cell population maintenance | 1.72% (2/116) | 5.49 | 0.000894 | 0.011512 |
GO:0003300 | cardiac muscle hypertrophy | 1.72% (2/116) | 5.49 | 0.000894 | 0.011512 |
GO:0014896 | muscle hypertrophy | 1.72% (2/116) | 5.49 | 0.000894 | 0.011512 |
GO:0014897 | striated muscle hypertrophy | 1.72% (2/116) | 5.49 | 0.000894 | 0.011512 |
GO:0000768 | syncytium formation by plasma membrane fusion | 1.72% (2/116) | 5.49 | 0.000894 | 0.011512 |
GO:0140253 | cell-cell fusion | 1.72% (2/116) | 5.49 | 0.000894 | 0.011512 |
GO:0051239 | regulation of multicellular organismal process | 17.24% (20/116) | 1.1 | 0.000909 | 0.011603 |
GO:0060828 | regulation of canonical Wnt signaling pathway | 3.45% (4/116) | 3.23 | 0.000919 | 0.011637 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 7.76% (9/116) | 1.86 | 0.000908 | 0.011649 |
GO:0018193 | peptidyl-amino acid modification | 8.62% (10/116) | 1.73 | 0.000918 | 0.011674 |
GO:0051241 | negative regulation of multicellular organismal process | 8.62% (10/116) | 1.74 | 0.000891 | 0.011772 |
GO:0009892 | negative regulation of metabolic process | 17.24% (20/116) | 1.1 | 0.000945 | 0.011917 |
GO:0051046 | regulation of secretion | 4.31% (5/116) | 2.74 | 0.00096 | 0.012054 |
GO:0016604 | nuclear body | 6.9% (8/116) | 1.99 | 0.000968 | 0.012109 |
GO:0048027 | mRNA 5'-UTR binding | 2.59% (3/116) | 3.96 | 0.000973 | 0.01212 |
GO:0016192 | vesicle-mediated transport | 8.62% (10/116) | 1.71 | 0.000995 | 0.012303 |
GO:0097367 | carbohydrate derivative binding | 15.52% (18/116) | 1.17 | 0.000992 | 0.012314 |
GO:0048534 | hematopoietic or lymphoid organ development | 3.45% (4/116) | 3.19 | 0.001017 | 0.012371 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 2.59% (3/116) | 3.94 | 0.001017 | 0.012418 |
GO:0006413 | translational initiation | 2.59% (3/116) | 3.94 | 0.001017 | 0.012418 |
GO:0003012 | muscle system process | 2.59% (3/116) | 3.94 | 0.001017 | 0.012418 |
GO:0031647 | regulation of protein stability | 5.17% (6/116) | 2.39 | 0.001063 | 0.01288 |
GO:0006397 | mRNA processing | 6.03% (7/116) | 2.15 | 0.001083 | 0.013014 |
GO:0060341 | regulation of cellular localization | 6.9% (8/116) | 1.96 | 0.001092 | 0.013029 |
GO:0009891 | positive regulation of biosynthetic process | 14.66% (17/116) | 1.2 | 0.00108 | 0.013032 |
GO:0051128 | regulation of cellular component organization | 13.79% (16/116) | 1.25 | 0.001099 | 0.013052 |
GO:0044260 | cellular macromolecule metabolic process | 18.1% (21/116) | 1.05 | 0.001091 | 0.013057 |
GO:0016859 | cis-trans isomerase activity | 2.59% (3/116) | 3.89 | 0.001109 | 0.013123 |
GO:0033962 | P-body assembly | 1.72% (2/116) | 5.31 | 0.001153 | 0.01339 |
GO:0001944 | vasculature development | 1.72% (2/116) | 5.31 | 0.001153 | 0.01339 |
GO:0090382 | phagosome maturation | 1.72% (2/116) | 5.31 | 0.001153 | 0.01339 |
GO:0014888 | striated muscle adaptation | 1.72% (2/116) | 5.31 | 0.001153 | 0.01339 |
GO:0051603 | proteolysis involved in protein catabolic process | 7.76% (9/116) | 1.8 | 0.001169 | 0.013523 |
GO:0045335 | phagocytic vesicle | 3.45% (4/116) | 3.14 | 0.00115 | 0.013559 |
GO:0042327 | positive regulation of phosphorylation | 4.31% (5/116) | 2.66 | 0.00122 | 0.014052 |
GO:0006399 | tRNA metabolic process | 5.17% (6/116) | 2.34 | 0.001243 | 0.014215 |
GO:0003008 | system process | 6.9% (8/116) | 1.93 | 0.001241 | 0.014242 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 2.59% (3/116) | 3.83 | 0.001257 | 0.014317 |
GO:0043500 | muscle adaptation | 1.72% (2/116) | 5.23 | 0.001295 | 0.014593 |
GO:0016018 | cyclosporin A binding | 1.72% (2/116) | 5.23 | 0.001295 | 0.014593 |
GO:0008135 | translation factor activity, RNA binding | 3.45% (4/116) | 3.09 | 0.001295 | 0.0147 |
GO:0032879 | regulation of localization | 12.07% (14/116) | 1.33 | 0.001342 | 0.015064 |
GO:0030658 | transport vesicle membrane | 2.59% (3/116) | 3.79 | 0.001362 | 0.01512 |
GO:2000146 | negative regulation of cell motility | 2.59% (3/116) | 3.79 | 0.001362 | 0.01512 |
GO:0070647 | protein modification by small protein conjugation or removal | 9.48% (11/116) | 1.56 | 0.001353 | 0.01513 |
GO:0009057 | macromolecule catabolic process | 10.34% (12/116) | 1.46 | 0.001405 | 0.015547 |
GO:0008134 | transcription factor binding | 6.03% (7/116) | 2.08 | 0.001423 | 0.015686 |
GO:0008139 | nuclear localization sequence binding | 1.72% (2/116) | 5.15 | 0.001445 | 0.015756 |
GO:0061608 | nuclear import signal receptor activity | 1.72% (2/116) | 5.15 | 0.001445 | 0.015756 |
GO:0045596 | negative regulation of cell differentiation | 4.31% (5/116) | 2.61 | 0.001435 | 0.015762 |
GO:0044265 | cellular macromolecule catabolic process | 8.62% (10/116) | 1.63 | 0.001498 | 0.016286 |
GO:0006355 | regulation of DNA-templated transcription | 18.1% (21/116) | 1.01 | 0.001513 | 0.01639 |
GO:0006364 | rRNA processing | 5.17% (6/116) | 2.28 | 0.001536 | 0.016524 |
GO:1903047 | mitotic cell cycle process | 6.9% (8/116) | 1.89 | 0.001532 | 0.016529 |
GO:0010243 | response to organonitrogen compound | 11.21% (13/116) | 1.37 | 0.001557 | 0.016625 |
GO:0045182 | translation regulator activity | 4.31% (5/116) | 2.58 | 0.001552 | 0.016636 |
GO:1903506 | regulation of nucleic acid-templated transcription | 18.1% (21/116) | 1.0 | 0.001567 | 0.016682 |
GO:1901698 | response to nitrogen compound | 12.07% (14/116) | 1.31 | 0.001588 | 0.016723 |
GO:2001141 | regulation of RNA biosynthetic process | 18.1% (21/116) | 1.0 | 0.001578 | 0.016741 |
GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 2.59% (3/116) | 3.71 | 0.001588 | 0.016779 |
GO:0051130 | positive regulation of cellular component organization | 6.9% (8/116) | 1.87 | 0.001626 | 0.017008 |
GO:0007163 | establishment or maintenance of cell polarity | 3.45% (4/116) | 3.0 | 0.001622 | 0.017024 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 6.9% (8/116) | 1.87 | 0.00164 | 0.017037 |
GO:0042325 | regulation of phosphorylation | 6.03% (7/116) | 2.04 | 0.001638 | 0.017072 |
GO:0045595 | regulation of cell differentiation | 7.76% (9/116) | 1.73 | 0.001665 | 0.017242 |
GO:0019941 | modification-dependent protein catabolic process | 6.9% (8/116) | 1.86 | 0.001696 | 0.017503 |
GO:0043067 | regulation of programmed cell death | 8.62% (10/116) | 1.61 | 0.001702 | 0.017508 |
GO:0030117 | membrane coat | 2.59% (3/116) | 3.68 | 0.001709 | 0.017518 |
GO:0016310 | phosphorylation | 12.07% (14/116) | 1.29 | 0.001733 | 0.017642 |
GO:0060627 | regulation of vesicle-mediated transport | 5.17% (6/116) | 2.25 | 0.001732 | 0.017698 |
GO:0032559 | adenyl ribonucleotide binding | 12.93% (15/116) | 1.23 | 0.001806 | 0.018332 |
GO:0098827 | endoplasmic reticulum subcompartment | 3.45% (4/116) | 2.95 | 0.001843 | 0.018585 |
GO:0007165 | signal transduction | 19.83% (23/116) | 0.93 | 0.001842 | 0.018631 |
GO:0030554 | adenyl nucleotide binding | 12.93% (15/116) | 1.22 | 0.001898 | 0.018945 |
GO:0032880 | regulation of protein localization | 6.03% (7/116) | 2.01 | 0.001895 | 0.01898 |
GO:0048731 | system development | 8.62% (10/116) | 1.59 | 0.001891 | 0.019002 |
GO:0000139 | Golgi membrane | 6.03% (7/116) | 2.0 | 0.001913 | 0.019038 |
GO:0000338 | protein deneddylation | 1.72% (2/116) | 4.94 | 0.00194 | 0.01912 |
GO:0010458 | exit from mitosis | 1.72% (2/116) | 4.94 | 0.00194 | 0.01912 |
GO:0031138 | negative regulation of conjugation with cellular fusion | 1.72% (2/116) | 4.94 | 0.00194 | 0.01912 |
GO:0031301 | integral component of organelle membrane | 4.31% (5/116) | 2.5 | 0.001976 | 0.019414 |
GO:0008033 | tRNA processing | 4.31% (5/116) | 2.5 | 0.002005 | 0.019636 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 2.59% (3/116) | 3.59 | 0.002037 | 0.019884 |
GO:0044092 | negative regulation of molecular function | 6.9% (8/116) | 1.82 | 0.00205 | 0.01995 |
GO:0044087 | regulation of cellular component biogenesis | 6.9% (8/116) | 1.82 | 0.002067 | 0.020049 |
GO:1901652 | response to peptide | 4.31% (5/116) | 2.48 | 0.002094 | 0.020249 |
GO:0042149 | cellular response to glucose starvation | 1.72% (2/116) | 4.87 | 0.002121 | 0.02025 |
GO:0070262 | peptidyl-serine dephosphorylation | 1.72% (2/116) | 4.87 | 0.002121 | 0.02025 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 5.17% (6/116) | 2.19 | 0.002132 | 0.020291 |
GO:0040013 | negative regulation of locomotion | 2.59% (3/116) | 3.57 | 0.002107 | 0.020309 |
GO:0043632 | modification-dependent macromolecule catabolic process | 6.9% (8/116) | 1.81 | 0.002118 | 0.020346 |
GO:0051098 | regulation of binding | 4.31% (5/116) | 2.45 | 0.002313 | 0.021747 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 1.72% (2/116) | 4.81 | 0.002309 | 0.021776 |
GO:0030335 | positive regulation of cell migration | 3.45% (4/116) | 2.87 | 0.002302 | 0.021781 |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | 2.59% (3/116) | 3.52 | 0.002326 | 0.021802 |
GO:0010033 | response to organic substance | 29.31% (34/116) | 0.69 | 0.002298 | 0.021804 |
GO:0050804 | modulation of chemical synaptic transmission | 3.45% (4/116) | 2.86 | 0.002348 | 0.021871 |
GO:0099177 | regulation of trans-synaptic signaling | 3.45% (4/116) | 2.86 | 0.002348 | 0.021871 |
GO:0031328 | positive regulation of cellular biosynthetic process | 13.79% (16/116) | 1.14 | 0.002367 | 0.021981 |
GO:2000147 | positive regulation of cell motility | 3.45% (4/116) | 2.85 | 0.002394 | 0.022164 |
GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.59% (3/116) | 3.51 | 0.002402 | 0.022175 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 3.45% (4/116) | 2.84 | 0.00244 | 0.022392 |
GO:0043068 | positive regulation of programmed cell death | 5.17% (6/116) | 2.15 | 0.002434 | 0.022405 |
GO:0034243 | regulation of transcription elongation by RNA polymerase II | 2.59% (3/116) | 3.49 | 0.002479 | 0.022685 |
GO:0006997 | nucleus organization | 3.45% (4/116) | 2.83 | 0.002487 | 0.022689 |
GO:0016072 | rRNA metabolic process | 5.17% (6/116) | 2.14 | 0.002515 | 0.022736 |
GO:0051336 | regulation of hydrolase activity | 5.17% (6/116) | 2.14 | 0.002515 | 0.022736 |
GO:0035145 | exon-exon junction complex | 1.72% (2/116) | 4.75 | 0.002505 | 0.022783 |
GO:0032786 | positive regulation of DNA-templated transcription, elongation | 2.59% (3/116) | 3.47 | 0.002558 | 0.023064 |
GO:0016874 | ligase activity | 4.31% (5/116) | 2.41 | 0.002618 | 0.023534 |
GO:0052472 | modulation by host of symbiont transcription | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0002191 | cap-dependent translational initiation | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0098808 | mRNA cap binding | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0070903 | mitochondrial tRNA thio-modification | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:2001159 | regulation of protein localization by the Cvt pathway | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:1903837 | regulation of mRNA 3'-UTR binding | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:1903839 | positive regulation of mRNA 3'-UTR binding | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0002153 | steroid receptor RNA activator RNA binding | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0106032 | snRNA pseudouridine synthase activity | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0048070 | regulation of developmental pigmentation | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0120305 | regulation of pigmentation | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0045617 | negative regulation of keratinocyte differentiation | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0052918 | dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0052926 | dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0071958 | new mitotic spindle pole body | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0022037 | metencephalon development | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0036408 | histone acetyltransferase activity (H3-K14 specific) | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0043992 | histone acetyltransferase activity (H3-K9 specific) | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0043993 | histone acetyltransferase activity (H3-K18 specific) | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0043997 | histone acetyltransferase activity (H4-K12 specific) | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0106075 | peptide N-succinyltransferase activity | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0106078 | histone succinyltransferase activity | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0106227 | peptidyl-lysine glutarylation | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0106228 | peptide glutaryltransferase activity | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0106229 | histone glutaryltransferase activity | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:1903010 | regulation of bone development | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:2000233 | negative regulation of rRNA processing | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:1902716 | cell cortex of growing cell tip | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0061666 | UFM1 ligase activity | 0.86% (1/116) | 8.4 | 0.002968 | 0.023626 |
GO:0050708 | regulation of protein secretion | 2.59% (3/116) | 3.4 | 0.002977 | 0.023638 |
GO:0030111 | regulation of Wnt signaling pathway | 3.45% (4/116) | 2.76 | 0.002993 | 0.023646 |
GO:0070585 | protein localization to mitochondrion | 2.59% (3/116) | 3.46 | 0.002639 | 0.023651 |
GO:0034285 | response to disaccharide | 4.31% (5/116) | 2.37 | 0.002991 | 0.023686 |
GO:0097470 | ribbon synapse | 1.72% (2/116) | 4.7 | 0.002709 | 0.023924 |
GO:0031453 | positive regulation of heterochromatin formation | 1.72% (2/116) | 4.7 | 0.002709 | 0.023924 |
GO:0120263 | positive regulation of heterochromatin organization | 1.72% (2/116) | 4.7 | 0.002709 | 0.023924 |
GO:0140142 | nucleocytoplasmic carrier activity | 1.72% (2/116) | 4.7 | 0.002709 | 0.023924 |
GO:0051338 | regulation of transferase activity | 5.17% (6/116) | 2.09 | 0.00304 | 0.023954 |
GO:0016050 | vesicle organization | 4.31% (5/116) | 2.4 | 0.00269 | 0.024037 |
GO:0048754 | branching morphogenesis of an epithelial tube | 1.72% (2/116) | 4.59 | 0.003138 | 0.024662 |
GO:0051783 | regulation of nuclear division | 3.45% (4/116) | 2.74 | 0.003158 | 0.024692 |
GO:0098852 | lytic vacuole membrane | 3.45% (4/116) | 2.74 | 0.003158 | 0.024692 |
GO:0008285 | negative regulation of cell population proliferation | 4.31% (5/116) | 2.38 | 0.002837 | 0.024991 |
GO:0098978 | glutamatergic synapse | 3.45% (4/116) | 2.73 | 0.003214 | 0.025004 |
GO:0090079 | translation regulator activity, nucleic acid binding | 3.45% (4/116) | 2.73 | 0.003214 | 0.025004 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.59% (3/116) | 3.41 | 0.00289 | 0.025237 |
GO:0009744 | response to sucrose | 4.31% (5/116) | 2.38 | 0.002875 | 0.025251 |
GO:0043086 | negative regulation of catalytic activity | 5.17% (6/116) | 2.1 | 0.002887 | 0.025279 |
GO:0000166 | nucleotide binding | 18.97% (22/116) | 0.9 | 0.002935 | 0.025411 |
GO:1901265 | nucleoside phosphate binding | 18.97% (22/116) | 0.9 | 0.002935 | 0.025411 |
GO:0048025 | negative regulation of mRNA splicing, via spliceosome | 1.72% (2/116) | 4.64 | 0.00292 | 0.025421 |
GO:0000785 | chromatin | 5.17% (6/116) | 2.06 | 0.003365 | 0.026114 |
GO:0031056 | regulation of histone modification | 4.31% (5/116) | 2.32 | 0.0034 | 0.026315 |
GO:0019900 | kinase binding | 6.9% (8/116) | 1.7 | 0.003423 | 0.026429 |
GO:0030177 | positive regulation of Wnt signaling pathway | 2.59% (3/116) | 3.32 | 0.003435 | 0.026454 |
GO:0003682 | chromatin binding | 6.03% (7/116) | 1.85 | 0.003478 | 0.026715 |
GO:0040017 | positive regulation of locomotion | 3.45% (4/116) | 2.7 | 0.003506 | 0.026861 |
GO:0099080 | supramolecular complex | 7.76% (9/116) | 1.56 | 0.003594 | 0.027473 |
GO:0006400 | tRNA modification | 3.45% (4/116) | 2.68 | 0.003627 | 0.027653 |
GO:0061138 | morphogenesis of a branching epithelium | 1.72% (2/116) | 4.44 | 0.003838 | 0.028974 |
GO:1902116 | negative regulation of organelle assembly | 1.72% (2/116) | 4.44 | 0.003838 | 0.028974 |
GO:0030490 | maturation of SSU-rRNA | 2.59% (3/116) | 3.27 | 0.003831 | 0.029066 |
GO:0044877 | protein-containing complex binding | 7.76% (9/116) | 1.55 | 0.003828 | 0.029117 |
GO:0007346 | regulation of mitotic cell cycle | 5.17% (6/116) | 2.01 | 0.003901 | 0.029306 |
GO:0016607 | nuclear speck | 4.31% (5/116) | 2.28 | 0.003895 | 0.029332 |
GO:0009141 | nucleoside triphosphate metabolic process | 3.45% (4/116) | 2.65 | 0.003943 | 0.029547 |
GO:0043434 | response to peptide hormone | 3.45% (4/116) | 2.64 | 0.004008 | 0.029963 |
GO:0043409 | negative regulation of MAPK cascade | 2.59% (3/116) | 3.24 | 0.004039 | 0.030122 |
GO:1905269 | positive regulation of chromatin organization | 1.72% (2/116) | 4.4 | 0.004086 | 0.030249 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 1.72% (2/116) | 4.4 | 0.004086 | 0.030249 |
GO:0003729 | mRNA binding | 10.34% (12/116) | 1.28 | 0.004073 | 0.030302 |
GO:1900180 | regulation of protein localization to nucleus | 2.59% (3/116) | 3.23 | 0.004146 | 0.030471 |
GO:0051604 | protein maturation | 3.45% (4/116) | 2.63 | 0.004141 | 0.03051 |
GO:0031300 | intrinsic component of organelle membrane | 4.31% (5/116) | 2.25 | 0.004136 | 0.030549 |
GO:0090158 | endoplasmic reticulum membrane organization | 1.72% (2/116) | 4.35 | 0.004341 | 0.031831 |
GO:0032784 | regulation of DNA-templated transcription elongation | 2.59% (3/116) | 3.19 | 0.004475 | 0.03266 |
GO:0008237 | metallopeptidase activity | 2.59% (3/116) | 3.19 | 0.004475 | 0.03266 |
GO:0048511 | rhythmic process | 6.03% (7/116) | 1.78 | 0.004503 | 0.032785 |
GO:0046928 | regulation of neurotransmitter secretion | 1.72% (2/116) | 4.31 | 0.004604 | 0.033278 |
GO:0051588 | regulation of neurotransmitter transport | 1.72% (2/116) | 4.31 | 0.004604 | 0.033278 |
GO:0036094 | small molecule binding | 19.83% (23/116) | 0.82 | 0.004626 | 0.033364 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 6.9% (8/116) | 1.63 | 0.004594 | 0.033365 |
GO:0050877 | nervous system process | 4.31% (5/116) | 2.21 | 0.004704 | 0.033611 |
GO:2000026 | regulation of multicellular organismal development | 12.07% (14/116) | 1.13 | 0.004681 | 0.033678 |
GO:0030496 | midbody | 2.59% (3/116) | 3.16 | 0.004704 | 0.033685 |
GO:0006470 | protein dephosphorylation | 3.45% (4/116) | 2.58 | 0.004702 | 0.033753 |
GO:0043227 | membrane-bounded organelle | 47.41% (55/116) | 0.43 | 0.004754 | 0.033809 |
GO:0051240 | positive regulation of multicellular organismal process | 7.76% (9/116) | 1.5 | 0.004744 | 0.033812 |
GO:0140098 | catalytic activity, acting on RNA | 6.03% (7/116) | 1.75 | 0.00498 | 0.03533 |
GO:0045202 | synapse | 5.17% (6/116) | 1.94 | 0.005021 | 0.035544 |
GO:0030234 | enzyme regulator activity | 6.9% (8/116) | 1.6 | 0.005113 | 0.036108 |
GO:0015986 | proton motive force-driven ATP synthesis | 1.72% (2/116) | 4.23 | 0.00515 | 0.036285 |
GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0006481 | C-terminal protein methylation | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0044789 | obsolete modulation by host of viral release from host cell | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0050816 | phosphothreonine residue binding | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:2000749 | positive regulation of rDNA heterochromatin formation | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0008928 | mannose-1-phosphate guanylyltransferase (GDP) activity | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0010471 | GDP-galactose:mannose-1-phosphate guanylyltransferase activity | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0010472 | GDP-galactose:glucose-1-phosphate guanylyltransferase activity | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0010473 | GDP-galactose:myoinositol-1-phosphate guanylyltransferase activity | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0080048 | GDP-D-glucose phosphorylase activity | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0042101 | T cell receptor complex | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:1900210 | positive regulation of cardiolipin metabolic process | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:1900437 | regulation of filamentous growth of a population of unicellular organisms in response to chemical stimulus | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:1900439 | positive regulation of filamentous growth of a population of unicellular organisms in response to chemical stimulus | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0090244 | Wnt signaling pathway involved in somitogenesis | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0090249 | regulation of cell migration involved in somitogenic axis elongation | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0106029 | tRNA pseudouridine synthase activity | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0004377 | GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0003157 | endocardium development | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0060800 | regulation of cell differentiation involved in embryonic placenta development | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0090168 | Golgi reassembly | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:1904235 | regulation of substrate-dependent cell migration, cell attachment to substrate | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:1904237 | positive regulation of substrate-dependent cell migration, cell attachment to substrate | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0034286 | response to maltose | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0045589 | regulation of regulatory T cell differentiation | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0014724 | regulation of twitch skeletal muscle contraction | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0031673 | H zone | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0031775 | lutropin-choriogonadotropic hormone receptor binding | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0045988 | negative regulation of striated muscle contraction | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0045989 | positive regulation of striated muscle contraction | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0051659 | maintenance of mitochondrion location | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0090076 | relaxation of skeletal muscle | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction | 0.86% (1/116) | 7.4 | 0.005927 | 0.037223 |
GO:0016485 | protein processing | 2.59% (3/116) | 3.04 | 0.005951 | 0.037301 |
GO:0031974 | membrane-enclosed lumen | 6.9% (8/116) | 1.59 | 0.005354 | 0.037463 |
GO:0043233 | organelle lumen | 6.9% (8/116) | 1.59 | 0.005354 | 0.037463 |
GO:0070013 | intracellular organelle lumen | 6.9% (8/116) | 1.59 | 0.005354 | 0.037463 |
GO:0009628 | response to abiotic stimulus | 29.31% (34/116) | 0.61 | 0.005452 | 0.037553 |
GO:0010942 | positive regulation of cell death | 5.17% (6/116) | 1.91 | 0.005443 | 0.037572 |
GO:0031063 | regulation of histone deacetylation | 1.72% (2/116) | 4.19 | 0.005434 | 0.037593 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.72% (2/116) | 4.19 | 0.005434 | 0.037593 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 1.72% (2/116) | 4.19 | 0.005434 | 0.037593 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 1.72% (2/116) | 4.19 | 0.005434 | 0.037593 |
GO:0012510 | trans-Golgi network transport vesicle membrane | 1.72% (2/116) | 4.11 | 0.006022 | 0.037669 |
GO:0031090 | organelle membrane | 21.55% (25/116) | 0.75 | 0.006055 | 0.037722 |
GO:0070887 | cellular response to chemical stimulus | 14.66% (17/116) | 0.96 | 0.006043 | 0.037722 |
GO:0033554 | cellular response to stress | 17.24% (20/116) | 0.87 | 0.006095 | 0.037893 |
GO:0043523 | regulation of neuron apoptotic process | 2.59% (3/116) | 3.09 | 0.005431 | 0.037918 |
GO:0010506 | regulation of autophagy | 3.45% (4/116) | 2.51 | 0.005555 | 0.038172 |
GO:0051726 | regulation of cell cycle | 7.76% (9/116) | 1.46 | 0.005592 | 0.038342 |
GO:0010638 | positive regulation of organelle organization | 4.31% (5/116) | 2.15 | 0.005627 | 0.038498 |
GO:1903320 | regulation of protein modification by small protein conjugation or removal | 3.45% (4/116) | 2.46 | 0.006235 | 0.038687 |
GO:0044232 | organelle membrane contact site | 1.72% (2/116) | 4.15 | 0.005724 | 0.038903 |
GO:2001235 | positive regulation of apoptotic signaling pathway | 1.72% (2/116) | 4.15 | 0.005724 | 0.038903 |
GO:0051881 | regulation of mitochondrial membrane potential | 1.72% (2/116) | 4.15 | 0.005724 | 0.038903 |
GO:1903305 | regulation of regulated secretory pathway | 1.72% (2/116) | 4.07 | 0.006327 | 0.039018 |
GO:0033119 | negative regulation of RNA splicing | 1.72% (2/116) | 4.07 | 0.006327 | 0.039018 |
GO:0043393 | regulation of protein binding | 2.59% (3/116) | 3.0 | 0.00636 | 0.039144 |
GO:0031330 | negative regulation of cellular catabolic process | 3.45% (4/116) | 2.45 | 0.006324 | 0.039159 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 12.07% (14/116) | 1.08 | 0.006434 | 0.039522 |
GO:0010941 | regulation of cell death | 8.62% (10/116) | 1.36 | 0.005864 | 0.039765 |
GO:0009583 | detection of light stimulus | 2.59% (3/116) | 2.98 | 0.006642 | 0.040312 |
GO:1903532 | positive regulation of secretion by cell | 2.59% (3/116) | 2.98 | 0.006642 | 0.040312 |
GO:0005741 | mitochondrial outer membrane | 2.59% (3/116) | 2.98 | 0.006642 | 0.040312 |
GO:2000058 | regulation of ubiquitin-dependent protein catabolic process | 3.45% (4/116) | 2.43 | 0.006688 | 0.04051 |
GO:0035306 | positive regulation of dephosphorylation | 1.72% (2/116) | 4.04 | 0.006638 | 0.040532 |
GO:0035198 | miRNA binding | 1.72% (2/116) | 4.04 | 0.006638 | 0.040532 |
GO:0005739 | mitochondrion | 11.21% (13/116) | 1.13 | 0.006621 | 0.04059 |
GO:0061025 | membrane fusion | 2.59% (3/116) | 2.97 | 0.006786 | 0.041021 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4.31% (5/116) | 2.08 | 0.006881 | 0.041514 |
GO:0051047 | positive regulation of secretion | 2.59% (3/116) | 2.96 | 0.006931 | 0.041572 |
GO:0009504 | cell plate | 2.59% (3/116) | 2.96 | 0.006931 | 0.041572 |
GO:0046649 | lymphocyte activation | 2.59% (3/116) | 2.96 | 0.006931 | 0.041572 |
GO:0030718 | germ-line stem cell population maintenance | 1.72% (2/116) | 4.0 | 0.006957 | 0.041647 |
GO:0006468 | protein phosphorylation | 9.48% (11/116) | 1.24 | 0.007127 | 0.042582 |
GO:0099522 | cytosolic region | 1.72% (2/116) | 3.97 | 0.007282 | 0.043173 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.72% (2/116) | 3.97 | 0.007282 | 0.043173 |
GO:0043502 | regulation of muscle adaptation | 1.72% (2/116) | 3.97 | 0.007282 | 0.043173 |
GO:0031137 | regulation of conjugation with cellular fusion | 1.72% (2/116) | 3.97 | 0.007282 | 0.043173 |
GO:0035770 | ribonucleoprotein granule | 4.31% (5/116) | 2.06 | 0.007314 | 0.043278 |
GO:0010822 | positive regulation of mitochondrion organization | 1.72% (2/116) | 3.94 | 0.007614 | 0.044881 |
GO:1903311 | regulation of mRNA metabolic process | 4.31% (5/116) | 2.04 | 0.007613 | 0.044962 |
GO:0035239 | tube morphogenesis | 2.59% (3/116) | 2.89 | 0.007843 | 0.046138 |
GO:0019901 | protein kinase binding | 5.17% (6/116) | 1.8 | 0.007884 | 0.04629 |
GO:0001917 | photoreceptor inner segment | 1.72% (2/116) | 3.9 | 0.007953 | 0.046343 |
GO:0048497 | maintenance of floral organ identity | 1.72% (2/116) | 3.9 | 0.007953 | 0.046343 |
GO:0090700 | maintenance of plant organ identity | 1.72% (2/116) | 3.9 | 0.007953 | 0.046343 |
GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.72% (2/116) | 3.9 | 0.007953 | 0.046343 |
GO:0008230 | ecdysone receptor holocomplex | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0008231 | repressor ecdysone receptor complex | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0022624 | proteasome accessory complex | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0090367 | negative regulation of mRNA modification | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:1905933 | regulation of cell fate determination | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0003373 | dynamin family protein polymerization involved in membrane fission | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0003374 | dynamin family protein polymerization involved in mitochondrial fission | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0051433 | BH2 domain binding | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0090649 | response to oxygen-glucose deprivation | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0090650 | cellular response to oxygen-glucose deprivation | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:1905395 | response to flavonoid | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:1990910 | response to hypobaric hypoxia | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:2000302 | positive regulation of synaptic vesicle exocytosis | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0075525 | viral translational termination-reinitiation | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:1990221 | L-cysteine desulfurase complex | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0010876 | lipid localization | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0048264 | determination of ventral identity | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0033129 | obsolete positive regulation of histone phosphorylation | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:2001168 | positive regulation of histone H2B ubiquitination | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0045605 | negative regulation of epidermal cell differentiation | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0045616 | regulation of keratinocyte differentiation | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0045683 | negative regulation of epidermis development | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0000026 | alpha-1,2-mannosyltransferase activity | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0098592 | cytoplasmic side of apical plasma membrane | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0019780 | FAT10 activating enzyme activity | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0021764 | amygdala development | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0030867 | rough endoplasmic reticulum membrane | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0010835 | regulation of protein ADP-ribosylation | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0035073 | pupariation | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0061035 | regulation of cartilage development | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0007271 | synaptic transmission, cholinergic | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0010460 | positive regulation of heart rate | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0014801 | longitudinal sarcoplasmic reticulum | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0014819 | regulation of skeletal muscle contraction | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0014883 | transition between fast and slow fiber | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0016240 | autophagosome membrane docking | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0044548 | S100 protein binding | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0045932 | negative regulation of muscle contraction | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0055119 | relaxation of cardiac muscle | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0086039 | P-type calcium transporter activity involved in regulation of cardiac muscle cell membrane potential | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0090534 | calcium ion-transporting ATPase complex | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:1900121 | negative regulation of receptor binding | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:1990456 | mitochondrion-endoplasmic reticulum membrane tethering | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0071568 | UFM1 transferase activity | 0.86% (1/116) | 6.81 | 0.008877 | 0.04635 |
GO:0044772 | mitotic cell cycle phase transition | 2.59% (3/116) | 2.88 | 0.008001 | 0.046535 |
GO:0048468 | cell development | 6.03% (7/116) | 1.59 | 0.008969 | 0.046751 |
GO:1901998 | toxin transport | 1.72% (2/116) | 3.81 | 0.00901 | 0.046804 |
GO:0006949 | syncytium formation | 1.72% (2/116) | 3.81 | 0.00901 | 0.046804 |
GO:0003924 | GTPase activity | 3.45% (4/116) | 2.3 | 0.009049 | 0.046931 |
GO:0009743 | response to carbohydrate | 6.03% (7/116) | 1.62 | 0.008116 | 0.047111 |
GO:0048584 | positive regulation of response to stimulus | 12.93% (15/116) | 0.99 | 0.008183 | 0.047414 |
GO:0071013 | catalytic step 2 spliceosome | 2.59% (3/116) | 2.81 | 0.009164 | 0.047444 |
GO:0009056 | catabolic process | 15.52% (18/116) | 0.87 | 0.009217 | 0.047637 |
GO:0051254 | positive regulation of RNA metabolic process | 11.21% (13/116) | 1.09 | 0.008286 | 0.047916 |
GO:0006357 | regulation of transcription by RNA polymerase II | 8.62% (10/116) | 1.26 | 0.009309 | 0.048034 |
GO:0001933 | negative regulation of protein phosphorylation | 2.59% (3/116) | 2.8 | 0.009337 | 0.048099 |
GO:0090407 | organophosphate biosynthetic process | 5.17% (6/116) | 1.78 | 0.008334 | 0.048108 |
GO:0006754 | ATP biosynthetic process | 1.72% (2/116) | 3.78 | 0.009375 | 0.048211 |
GO:0031982 | vesicle | 12.07% (14/116) | 1.03 | 0.008406 | 0.048427 |
GO:0031984 | organelle subcompartment | 7.76% (9/116) | 1.34 | 0.009467 | 0.048524 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 12.07% (14/116) | 1.01 | 0.009457 | 0.048552 |
GO:0051099 | positive regulation of binding | 2.59% (3/116) | 2.85 | 0.008488 | 0.04881 |
GO:0019221 | cytokine-mediated signaling pathway | 1.72% (2/116) | 3.84 | 0.008651 | 0.049376 |
GO:0035148 | tube formation | 1.72% (2/116) | 3.84 | 0.008651 | 0.049376 |
GO:0051879 | Hsp90 protein binding | 1.72% (2/116) | 3.84 | 0.008651 | 0.049376 |
GO:0140101 | catalytic activity, acting on a tRNA | 3.45% (4/116) | 2.32 | 0.008605 | 0.049388 |
GO:0036503 | ERAD pathway | 2.59% (3/116) | 2.78 | 0.00969 | 0.049502 |
GO:1903322 | positive regulation of protein modification by small protein conjugation or removal | 2.59% (3/116) | 2.78 | 0.00969 | 0.049502 |